Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cancer
Pharma
Astellas wins class-first gastric cancer nod for Vyloy
Astellas' Vyloy won an FDA approval to treat gastric or gastroesophageal junction adenocarcinoma patients whose tumors are CLDN18.2 positive.
Fraiser Kansteiner
Oct 18, 2024 3:39pm
GSK emerges victorious in another trial over Zantac risks
Aug 6, 2024 11:28am
GSK notches Zantac win as plaintiff drops case in Illinois
Jun 11, 2024 7:53am
LGBTQ+ populations may face elevated cancer risk: ACS report
May 31, 2024 11:07am
AstraZeneca taps hard-hitting NHL star for cancer screening push
Apr 19, 2024 12:00pm
Kate Middleton's cancer reveal sends NHS searches skyrocketing
Mar 27, 2024 12:04pm